Tivic Health Systems, Inc. (TIVC): Price and Financial Metrics
GET POWR RATINGS... FREE!
TIVC Stock Price Chart Interactive Chart >
TIVC Price/Volume Stats
| Current price | $1.95 | 52-week high | $6.50 |
| Prev. close | $1.85 | 52-week low | $1.23 |
| Day low | $1.80 | Volume | 57,122 |
| Day high | $2.03 | Avg. volume | 180,980 |
| 50-day MA | $1.80 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 18.76M |
Tivic Health Systems, Inc. (TIVC) Company Bio
Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. The company's primary product, ClearUP, is a medical device intended to relieve sinus and nasal inflammation. It sells its products on direct-to-consumer channel through its own websites and platforms, such as Amazon.com, as well as to major U.S. online retailers, such as BestBuy.com, FSAStore.com, Walgreens.com, Walmart.com. The company was incorporated in 2016 and is headquartered in Newark, California.
Latest TIVC News From Around the Web
Below are the latest news stories about Tivic Health Systems Inc that investors may wish to consider to help them evaluate TIVC as an investment opportunity.
Tivic Health’s ClearUP Named Best Sinus Pain Relief Solution of 2021 by Global Health & Pharma MagazineSAN FRANCISCO, February 07, 2022--Tivic Health's ClearUP named Best Sinus Pain Relief Solution of 2021 by Global Health & Pharma Magazine. |
Tivic Featured in ABC News Report: "New Bioelectronic Technologies Could Signal the Future of Medicine"SAN FRANCISCO, January 31, 2022--Tivic Health (TIVC) was one of two companies featured in the ABC News story "New Bioelectronic Technologies Could Signal the Future of Medicine." |
Tivic Health Collaborates With Leading Medical Research Hospital on First Controlled Trial to Extend Tivic’s Bioelectronic PlatformSAN FRANCISCO, January 19, 2022--Tivic Health announces trial with research hospital to investigate bioelectronic therapeutic device as alternative to opioids after sinus surgeries. |
Tivic Health Names Mindgruve Digital Marketing Agency of RecordSAN FRANCISCO, December 20, 2021--Tivic Health (Nasdaq: TIVC) names Mindgruve as its digital marketing agency of record. |
Tivic Health Named to Fast Company’s Inaugural Next Big Things in TechSAN FRANCISCO, December 08, 2021--Tivic Health named to Fast Company's Next Big Things in Tech. CEO Jennifer Ernst receives Inc's 2021 Female Founders 100 award. |
TIVC Price Returns
| 1-mo | 3.72% |
| 3-mo | 25.00% |
| 6-mo | -39.25% |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -49.74% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...